Policymakers’ views on dengue fever/dengue haemorrhagic fever and the need for dengue vaccines in four southeast Asian countries
- 30 July 2003
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 22 (1), 121-129
- https://doi.org/10.1016/s0264-410x(03)00533-4
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- The future of dengue vaccinesThe Lancet, 2002
- Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st centuryTrends in Microbiology, 2002
- Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteersVaccine, 2001
- Dengue and Other Emerging FlavivirusesJournal of Infection, 2001
- DENGUE AND DENGUE HEMORRHAGIC FEVER IN LATIN AMERICA AND THE CARIBBEANInfectious Disease Clinics of North America, 2000
- Live attenuated tetravalent dengue vaccineVaccine, 2000
- Dengue: emergence as a global public health problem and prospects for controlTransactions of the Royal Society of Tropical Medicine and Hygiene, 2000
- Dengue Viremia Titer, Antibody Response Pattern, and Virus Serotype Correlate with Disease SeverityThe Journal of Infectious Diseases, 2000
- Dengue and dengue haemorrhagic feverThe Lancet, 1998
- Pathogenesis of Dengue: Challenges to Molecular BiologyScience, 1988